Ирландия - английский - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - aciclovir - dispersible tablet - 800 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Саудовская Аравия - английский - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxo saudi arabia, saudi arabia - acyclovir (aciclovir) - tablet - 400 mg

Саудовская Аравия - английский - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxo saudi arabia, saudi arabia - acyclovir (aciclovir) - tablet - 800 mg

ОАЭ - английский - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

25's( 5 x 5's blister) -

Саудовская Аравия - английский - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxo saudi arabia, saudi arabia - acyclovir - tablet - 400 mg

Саудовская Аравия - английский - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxo saudi arabia, saudi arabia - acyclovir - tablet - 800 mg

Ирландия - английский - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - aciclovir - dispersible tablet - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Ирландия - английский - HPRA (Health Products Regulatory Authority)

merit pharmaceuticals limited - aciclovir - dispersible tablet - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Ирландия - английский - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - aciclovir - dispersible tablet - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 556 mg (equivalent: valaciclovir, qty 500 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with zelitrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.